BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 28258794)

  • 1. Brain bioenergetics and redox state measured by
    Chouinard VA; Kim SY; Valeri L; Yuksel C; Ryan KP; Chouinard G; Cohen BM; Du F; Öngür D
    Schizophr Res; 2017 Sep; 187():11-16. PubMed ID: 28258794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redox Dysregulation in Schizophrenia Revealed by in vivo NAD+/NADH Measurement.
    Kim SY; Cohen BM; Chen X; Lukas SE; Shinn AK; Yuksel AC; Li T; Du F; Öngür D
    Schizophr Bull; 2017 Jan; 43(1):197-204. PubMed ID: 27665001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo evidence for cerebral bioenergetic abnormalities in schizophrenia measured using 31P magnetization transfer spectroscopy.
    Du F; Cooper AJ; Thida T; Sehovic S; Lukas SE; Cohen BM; Zhang X; Ongür D
    JAMA Psychiatry; 2014 Jan; 71(1):19-27. PubMed ID: 24196348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 1H-MRS investigation of the medial temporal lobe in antipsychotic-naïve and early-treated first episode psychosis.
    Wood SJ; Berger GE; Wellard RM; Proffitt T; McConchie M; Velakoulis D; McGorry PD; Pantelis C
    Schizophr Res; 2008 Jul; 102(1-3):163-70. PubMed ID: 18456460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased brain PME/PDE ratio in bipolar disorder: a preliminary (31) P magnetic resonance spectroscopy study.
    Shi XF; Carlson PJ; Sung YH; Fiedler KK; Forrest LN; Hellem TL; Huber RS; Kim SE; Zuo C; Jeong EK; Renshaw PF; Kondo DG
    Bipolar Disord; 2015 Nov; 17(7):743-52. PubMed ID: 26477793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo (31) P MRS assessment of intracellular NAD metabolites and NAD(+) /NADH redox state in human brain at 4 T.
    Lu M; Zhu XH; Chen W
    NMR Biomed; 2016 Jul; 29(7):1010-7. PubMed ID: 27257783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered phospholipid metabolism in schizophrenia: a phosphorus 31 nuclear magnetic resonance spectroscopy study.
    Weber-Fahr W; Englisch S; Esser A; Tunc-Skarka N; Meyer-Lindenberg A; Ende G; Zink M
    Psychiatry Res; 2013 Dec; 214(3):365-73. PubMed ID: 24045051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vivo Brain Glycine and Glutamate Concentrations in Patients With First-Episode Psychosis Measured by Echo Time-Averaged Proton Magnetic Resonance Spectroscopy at 4T.
    Kim SY; Kaufman MJ; Cohen BM; Jensen JE; Coyle JT; Du F; Öngür D
    Biol Psychiatry; 2018 Mar; 83(6):484-491. PubMed ID: 29031411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No progressive brain changes during a 1-year follow-up of patients with first-episode psychosis.
    Haukvik UK; Hartberg CB; Nerland S; Jørgensen KN; Lange EH; Simonsen C; Nesvåg R; Dale AM; Andreassen OA; Melle I; Agartz I
    Psychol Med; 2016 Feb; 46(3):589-98. PubMed ID: 26526001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grey and white matter differences in brain energy metabolism in first episode schizophrenia: 31P-MRS chemical shift imaging at 4 Tesla.
    Jensen JE; Miller J; Williamson PC; Neufeld RW; Menon RS; Malla A; Manchanda R; Schaefer B; Densmore M; Drost DJ
    Psychiatry Res; 2006 Mar; 146(2):127-35. PubMed ID: 16497488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular redox state revealed by in vivo (31) P MRS measurement of NAD(+) and NADH contents in brains.
    Lu M; Zhu XH; Zhang Y; Chen W
    Magn Reson Med; 2014 Jun; 71(6):1959-72. PubMed ID: 23843330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormalities in High-Energy Phosphate Metabolism in First-Episode Bipolar Disorder Measured Using
    Du F; Yuksel C; Chouinard VA; Huynh P; Ryan K; Cohen BM; Öngür D
    Biol Psychiatry; 2018 Dec; 84(11):797-802. PubMed ID: 28527566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frontal lobe bioenergetic metabolism in depressed adolescents with bipolar disorder: a phosphorus-31 magnetic resonance spectroscopy study.
    Shi XF; Kondo DG; Sung YH; Hellem TL; Fiedler KK; Jeong EK; Huber RS; Renshaw PF
    Bipolar Disord; 2012 Sep; 14(6):607-17. PubMed ID: 22816670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of hippocampal metabolism and regional brain grey matter in neuroleptic-naïve ultra-high-risk subjects and first-episode schizophrenia.
    Nenadic I; Maitra R; Basu S; Dietzek M; Schönfeld N; Lorenz C; Gussew A; Amminger GP; McGorry P; Reichenbach JR; Sauer H; Gaser C; Smesny S
    Eur Neuropsychopharmacol; 2015 Oct; 25(10):1661-8. PubMed ID: 26088723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creatine abnormalities in schizophrenia and bipolar disorder.
    Ongür D; Prescot AP; Jensen JE; Cohen BM; Renshaw PF
    Psychiatry Res; 2009 Apr; 172(1):44-8. PubMed ID: 19239984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic mapping using 2D 31P-MR spectroscopy reveals frontal and thalamic metabolic abnormalities in schizophrenia.
    Smesny S; Rosburg T; Nenadic I; Fenk KP; Kunstmann S; Rzanny R; Volz HP; Sauer H
    Neuroimage; 2007 Apr; 35(2):729-37. PubMed ID: 17276699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral bioenergetic differences measured by phosphorus-31 magnetic resonance spectroscopy between bipolar disorder and healthy subjects living in two different regions suggesting possible effects of altitude.
    Hwang J; DeLisi LE; Öngür D; Riley C; Zuo C; Shi X; Sung YH; Kondo D; Kim TS; Villafuerte R; Smedberg D; Yurgelun-Todd D; Renshaw PF
    Psychiatry Clin Neurosci; 2019 Sep; 73(9):581-589. PubMed ID: 31125152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations of phosphomonoesters measured by phosphorus-31 magnetic resonance spectroscopy in the frontal lobes and negative symptoms in schizophrenia.
    Shioiri T; Kato T; Inubushi T; Murashita J; Takahashi S
    Psychiatry Res; 1994 Dec; 55(4):223-35. PubMed ID: 7701036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Connectome organization is related to longitudinal changes in general functioning, symptoms and IQ in chronic schizophrenia.
    Collin G; de Nijs J; Hulshoff Pol HE; Cahn W; van den Heuvel MP
    Schizophr Res; 2016 Jun; 173(3):166-173. PubMed ID: 25843919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidant defense in schizophrenia and bipolar disorder: A meta-analysis of MRS studies of anterior cingulate glutathione.
    Das TK; Javadzadeh A; Dey A; Sabesan P; Théberge J; Radua J; Palaniyappan L
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Apr; 91():94-102. PubMed ID: 30125624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.